These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 8687181)

  • 1. A dopaminergic neurotoxin, (R)-N-methylsalsolinol, increases in Parkinsonian cerebrospinal fluid.
    Maruyama W; Abe T; Tohgi H; Dostert P; Naoi M
    Ann Neurol; 1996 Jul; 40(1):119-22. PubMed ID: 8687181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-methyl(R)salsolinol and a neutral N-methyltransferase as pathogenic factors in Parkinson's disease.
    Maruyama W; Strolin-Benedetti M; Naoi M
    Neurobiology (Bp); 2000; 8(1):55-68. PubMed ID: 11008878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An endogenous MPTP-like dopaminergic neurotoxin, N-methyl(R)salsolinol, in the cerebrospinal fluid decreases with progression of Parkinson's disease.
    Maruyama W; Abe T; Tohgi H; Naoi M
    Neurosci Lett; 1999 Feb; 262(1):13-6. PubMed ID: 10076861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-methyl(R)salsolinol, a dopamine neurotoxin, in Parkinson's disease.
    Naoi M; Maruyama W
    Adv Neurol; 1999; 80():259-64. PubMed ID: 10410730
    [No Abstract]   [Full Text] [Related]  

  • 5. Dopamine-derived endogenous N-methyl-(R)-salsolinol: its role in Parkinson's disease.
    Naoi M; Maruyama W; Akao Y; Yi H
    Neurotoxicol Teratol; 2002; 24(5):579-91. PubMed ID: 12200189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell death of dopamine neurons in aging and Parkinson's disease.
    Naoi M; Maruyama W
    Mech Ageing Dev; 1999 Nov; 111(2-3):175-88. PubMed ID: 10656535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-methyl-(R)salsolinol as a dopaminergic neurotoxin: from an animal model to an early marker of Parkinson's disease.
    Naoi M; Maruyama W; Dostert P; Hashizume Y
    J Neural Transm Suppl; 1997; 50():89-105. PubMed ID: 9120428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of endogenous N-methyl(R)salsolinol in Parkinson's disease: induction of apoptosis and protection by (-)deprenyl.
    Naoi M; Maruyama W; Takahashi T; Akao Y; Nakagawa Y
    J Neural Transm Suppl; 2000; (58):111-21. PubMed ID: 11128601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A dopaminergic neurotoxin, 1(R), 2(N)-dimethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline, N-methyl(R)salsolinol, and its oxidation product, 1,2(N)-dimethyl-6,7-dihydroxyisoquinolinium ion, accumulate in the nigro-striatal system of the human brain.
    Maruyama W; Sobue G; Matsubara K; Hashizume Y; Dostert P; Naoi M
    Neurosci Lett; 1997 Feb; 223(1):61-4. PubMed ID: 9058423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell death in Parkinson's disease.
    Maruyama W; Naoi M
    J Neurol; 2002 Sep; 249 Suppl 2():II6-10. PubMed ID: 12375057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pathogenesis of idiopathic Parkinson's disease].
    Maruyama W
    Nihon Ronen Igakkai Zasshi; 2001 Jul; 38(4):494-7. PubMed ID: 11523160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endogenous synthesis of N-methylsalsolinol, an analogue of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, in rat brain during in vivo microdialysis with salsolinol, as demonstrated by gas chromatography-mass spectrometry.
    Niwa T; Maruyama W; Nakahara D; Takeda N; Yoshizumi H; Tatematsu A; Takahashi A; Dostert P; Naoi M; Nagatsu T
    J Chromatogr; 1992 Jul; 578(1):109-15. PubMed ID: 1400775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation of reactive oxygen species accounts for cytotoxicity of an endogenous dopaminergic neurotoxin, (R)-N-methylsalsolinol, to differentiated dopaminergic SH-SY5Y cells.
    Minami C; Deng Y; Maruyama W; Takahashi T; Kawai M; Nakahara D; Naoi M
    J Neural Transm (Vienna); 1998; 105(4-5):397-405. PubMed ID: 9720969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apoptosis induced by an endogenous neurotoxin, N-methyl(R)salsolinol, in dopamine neurons.
    Naoi M; Maruyama W; Akao Y; Zhang J; Parvez H
    Toxicology; 2000 Nov; 153(1-3):123-41. PubMed ID: 11090952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Salsolinol, 3-O-methyl-dopa and homovanillic acid in the cerebrospinal fluid of Parkinson patients].
    Krygowska-Wajs A; Szczudlik A; Antkiewicz-Michaluk L; Romańska I; Vetulani J
    Neurol Neurochir Pol; 1997; 31(5):875-85. PubMed ID: 9513952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An endogenous dopaminergic neurotoxin, N-methyl-(R)-salsolinol, induces DNA damage in human dopaminergic neuroblastoma SH-SY5Y cells.
    Maruyama W; Naoi M; Kasamatsu T; Hashizume Y; Takahashi T; Kohda K; Dostert P
    J Neurochem; 1997 Jul; 69(1):322-9. PubMed ID: 9202326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endogenous dopamine-derived neurotoxins and Parkinson's disease.
    Deleu D
    Acta Neurol Belg; 1998 Dec; 98(4):319-21. PubMed ID: 9922818
    [No Abstract]   [Full Text] [Related]  

  • 18. Liquid chromatography with amperometric detection at a nano crystalline Ce-doped lead dioxide film modified electrode for determination of (R)-Salsolinol, (R)-N-methylsalsolinol and monoamine neurotransmitters in Parkinsonian patients' cerebrospinal fluid.
    Zhang W; Xie Y; Gu J; Ai S; Wang J; Yamamoto K; Jin L
    Analyst; 2004 Mar; 129(3):229-34. PubMed ID: 14978525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. No increase of synthesis of (R)salsolinol in Parkinson's disease.
    Müller T; Przuntek H; Kuhn W; Baum SS; Rommelspacher H
    Mov Disord; 1999 May; 14(3):514-5. PubMed ID: 10348481
    [No Abstract]   [Full Text] [Related]  

  • 20. [Studies on endogenous toxins as pathogenic factors in idiopathic parkinson's disease].
    Maruyama W; Naoi M
    Nihon Yakurigaku Zasshi; 2000 Dec; 116(6):333-42. PubMed ID: 11188501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.